The FDA approved the company's COVID vaccine in October 2023. The stock has gained 111% in the year to date, while the S&P 500 SPX has gained 22%. This content was created by MarketWatch, which is ...
A shortage of IV fluid in the wake of Hurricane Helene is shining a spotlight on the fragility and vulnerability of the ...
Lundbeck, una farmacéutica global con sede en Dinamarca, ha acordado comprar Longboard Pharmaceuticals, con sede en La Jolla, ...
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...
A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
A new and contagious COVID variant known as XEC, which has been spreading rapidly in other countries over the last few months ...
Despite past performance issues, Arvinas has a solid cash runway. Learn more about ARVN stock's potential and why a cautious ...
Patients with inflammatory bowel disease (IBD) who initially responded to the investigational monoclonal antibody ...
The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.
Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...
COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased ...
Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback